2288 Federal Register / Vol. 72, No. 11 / Thursday, January 18, 2007 / Notices 

Oct 2006 (HHS Reference No. E–190–

2003/0–US–04). 

Licensing Status: Available for 

exclusive or nonexclusive licensing. 

Licensing Contact: Tara Kirby, Ph.D.; 

301/435–4426; tarak@mail.nih.gov. 

Methods for Assaying Hair Follicle 

Growth and Development 

Description of Technology: Methods 

of culturing functionally-intact hair 

follicles in a collagen matrix are useful 

for screening baldness treatments and 

the quantification and study of the 

effects of agents on hair follicle growth. 

This technology describes techniques 

for measuring cell proliferation or for 

measuring secretion of collagenolytic 

factors, incorporating a threedimensional hair follicle culture system. 

Collagenolytic activity is essential for 

downgrowth of hair follicles during 

anagen. One described method 

measures the effects of a growth factor 

or pharmaceutical compound on cell 

proliferation, utilizing the incorporation 

of tritiated thymidine into DNA of 

cultured hair follicles. Also described is 

a method to measure the effect of 

growth factors on the release of 

collagenolytic factors, utilizing tritiated 

collagen or a fluorescent marker. 

Applications: Assays for screening 

drugs or growth factors that may 

stimulate hair growth; Assays measuring 

the DNA synthesis and collagenasesecreting activity of hair follicles. 

Market: An estimated 40 million men 

and 20 million women suffer from hair 

loss; The market size for hair restoration 

procedures in the United States is 

approximately $800 million. 

Inventor: Stuart H. Yuspa (NCI). 

Publications: 

1. G Rogers, N Martinet, P Steinert, P 

Wynn, D Roop, A Kilkenny, D Morgan, 

SH Yuspa. Cultivation of murine hair 

follicles as organoids in a collagen 

matrix. J Invest Dermatol. 1987 

Oct;89(4):369–379. 

2. W Weinberg, P Brown, WG StetlerStevenson, SH Yuspa, Growth factors 

specifically alter hair follicle cell 

proliferation and collagenolytic activity 

alone or in combination. Differentiation. 

1990 Dec;45(3):168–178. 

Patent Status: U.S. Patent No. 

5,616,471 issued 01 Apr 1997 (HHS 

Reference No. E–213–1987/1–US–01). 

Licensing Status: Available for 

nonexclusive licensing. 

Licensing Contact: Tara Kirby, Ph.D.; 

301/435–4426; tarak@mail.nih.gov. 

Dated: January 9, 2007. 

Steven M. Ferguson, 

Director, Division of Technology Development 

and Transfer, Office of Technology Transfer, 

National Institutes of Health. 

[FR Doc. E7–626 Filed 1–17–07; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Initial Review Group, Subcommittee 

G—Education. 

Date: February 6–7, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Washington Court Hotel, 525 New 

Jersey Avenue, NW., Washington, DC 20001. 

Contact Person: Sonya Roberson, PhD, 

Scientific Review Administrator, Resources 

and Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, 6116 Executive Blvd., Room 8109, 

Bethesda, MD 20892, 301–594–1182, 

robersos@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: January 9, 2007. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–178 Filed 1–17–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

National Heart, Lung, and Blood 

Advisory Council. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed blow in 

advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Advisory Council. 

Date: February 14, 2007. 

Open: 8 a.m. to 12 p.m. 

Agenda: Discussion of program policies 

and issues. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Conference 

Room 6, Bethesda, MD 20892. 

Closed: 1 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Conference 

Room 6, Bethesda, MD 20892. 

Contact Person: Stephen Mockrin, PhD, 

Director, Division of Extramural Research 

Activities, National Heart, Lung, and Blood 

Institute, National Institutes of Health, 6701 

Rockledge Drive, Room 7100, Bethesda, MD 

20892, (301) 435–0260, 

mockrins@nhlbi.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 


pwalker on PROD1PC71 with NOTICES
Federal Register / Vol. 72, No. 11 / Thursday, January 18, 2007 / Notices 2289 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

www.nhlbi.nih.gov/meetings/index.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Disease Research; 93.839, Blood Diseases and 

Resources Research, National Institutes of 

Health, HHS) 

Dated: January 10, 2007. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–176 Filed 1–17–07; 8:45 am] 

BILLING CODE 4140–07–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Human Genome Research 

Institute; Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended ( 5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

National Advisory Council for Human 

Genome Research. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Council for Human Genome Research. 

Date: February 12–13, 2007. 

Open: February 12, 2007, 8:30 a.m. to 3 

p.m. 

Agenda: Program documents. 

Place: National Institutes of Health, 5635 

Fishers Lane, Bethesda, MD 20892. 

Closed: February 12, 2007, 3 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 5635 

Fishers Lane, Bethesda, MD 20892. 

Closed: February 13, 2007, 8:30 a.m. to 5 

p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: National Institutes of Health, 5635 

Fishers Lane, Bethesda, MD 20892. 

Contact Person: Mark S. Guyer, PhD, 

Director for Extramural Research, National 

Human Genome Research Institute, 5635 

Fishers Lane, Suite 4076, MSC 9305, 

Bethesda, MD 20892, 301–496–7531, 

guyerm@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

www.genome.gov/11509849, where an 

agenda and any additional information for 

the meeting will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.172, Human Genome 

Research, National Institutes of Health, HHS) 

Dated: January 8, 2007. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–170 Filed 1–17–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2) notice 

is hereby given of a meeting of the 

National Advisory General Medical 

Sciences Council. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

General Medical Sciences Council. 

Date: January 25, 2007, 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, Conference Rooms E1 & 

E2, 9000 Rockville Pike, Bethesda, MD 

20852. 

Open: January 26, 2007, 8:30 a.m. to 

Adjournment. 

Agenda: For the discussion of program 

policies and issues, opening remarks, report 

of the Director, NIGMS, and other business 

of the Council. 

Place: National Institutes of Health, 

Natcher Building, Conference Rooms E1 & 

E2, 9000 Rockville Pike, Bethesda, MD 

20852. 

Contact Person: Ann A. Hagan, PhD, 

Associate Director for Extramural Activities, 

NIGMS, NIH, DHHS, 45 Center Drive, Room 

2AN24H, MSC6200, Bethesda, MD 20892–

6200, (301) 594–4499, 

hagana@nigms.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

www.nigms.nih.gov/about/ 

advisory_council.html, where an agenda and 

any additional information for the meeting 

will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.375, Minority Biomedical 

Research Support; 93.821, Cell Biology and 

Biophysics Research; 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.862, Genetics and 

Developmental Biology Research; 93.88, 

Minority Access to Research Careers; 93.96, 

Special Minority Initiatives, National 

Institutes of Health, HHS) 

Dated: January 10, 2007. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–168 Filed 1–17–07; 8:45 am] 

BILLING CODE 4140–01–M 


pwalker on PROD1PC71 with NOTICES